Locations:
Search IconSearch
April 24, 2020/Digestive

Perioperative Pain Perception and Analgesic Requirements in Pediatric Patients with Obesity

Study finds no significant association between BMI and pain following most noncardiac procedures

20-PAI-1882940_CQD_650x450_1157264031

There were 40 million children under the age of 5 and more than 340 million individuals between the ages of 5 and 19 whose BMI put them in the categories of overweight/obesity in 2018, according to the World Health Organization.1 Despite the increasing proportion of pediatric patients with obesity, there is little data about pain sensitivity and analgesic requirements in this population.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

In adult patients with obesity, evidence suggests different opioid requirements following surgery to achieve optimum recovery. This could be secondary to altered perception of pain and differences in pharmacokinetics and pharmacodynamics of analgesic medications. Unfortunately there is a lack of such clinical evidence among the population of pediatric patients with obesity. It is also unclear whether obese children should receive analgesics according to their ideal body weight, potentially exposing them to underdosing and sub-optimal pain control, or according to their actual body weight, with the inherent risks of toxicity and opioid-induced side effects, such as respiratory depression or nausea/vomiting.

To address this, in a single-center retrospective cohort study, led by Alparslan Turan, MD, Vice Chairman of Outcomes Research and Staff at Cleveland Clinic’s Anesthesiology Institute, Surendrasingh Chhabada, MD, a pediatric anesthesiologist with Cleveland Clinic Children’s, together with collaborators, analyzed postoperative pain scores and opioid consumption in opioid-naïve patients between the ages of 8 and 18 who had elective, noncardiac surgery with an inpatient stay of at least 48 hours at Cleveland Clinic Children’s between 2010 and 2015.2 The authors found no clinically important association between BMI and postoperative pain or opioid requirement. These results suggest that clinicians can follow a similar dosing approach in obese and non-obese patients between 8-18 years of age when administering opioids in the perioperative period.

References

  1. World Health Organization. Overweight and obesity. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Updated April 1, 2020. Retrieved August 24, 2020.
  2. Cohen B, Tanios MA, Koyuncu O, et al. Association between higher BMI and postoperative pain and opioid consumption in pediatric inpatients – a retrospective cohort study. J Clin Anesth. 2020 Jun;62:109729.

Advertisement

Related Articles

Matthew Kroh, MD with surgeons
July 5, 2024/Digestive/Innovation
How the Digestive Disease Innovations Program Empowers Caregivers to Be Ambassadors for Innovation

Insights from Cleveland Clinic’s Vice Chair of Innovation and Technology

Surgeons performing bariatric surgery
July 2, 2024/Digestive/Research
Bariatric Surgery Improves Cardiovascular Outcomes in Patients with Obstructive Sleep Apnea

Cleveland Clinic study finds that durable weight loss is key to health benefits

Stefan Holubar speaking with researcher
June 21, 2024/Digestive/Research
3D Pouchography Can Improve Pouch Dysfunction Diagnosis and Pouch Salvage Planning

A proof-of-concept study shows how 3D pouchography can be a useful adjunct for surgeons

David Liska, MD, MA
June 18, 2024/Digestive/Q&A
Meet David Liska, MD, MA, the New Chair of Colorectal Surgery

The new appointee brings special expertise in hereditary and young-onset colorectal cancer

Liver Perfusion Device
June 7, 2024/Digestive/Research
Machine Perfusion Reduces Mortality by Shortening Waitlist Times and Increasing Liver Transplantations

New research shows dramatic reduction in waitlist times with new technology

esophagus
May 24, 2024/Digestive/Research
Study Identifies Biomarkers in the Breath for Eosinophilic Esophagitis

Potential for new, non-invasive screening option

Patient holding injectable
May 23, 2024/Digestive/Research
Increased Risk of Gastroparesis Associated with GLP-1RA Use in Type 2 Diabetes Patients

Provider vigilance and patient education are key for management

Ad